Vireo Growth Inc. Announces Third Quarter 2026 Results
Globe Newswire•10/11/2026•06:30 ET
0
Key Highlights
- ➤Q3 GAAP revenue $253.7 million, up 176.7% year-over-year
- ➤Q3 adjusted EBITDA $42.7 million, up 68.1% year-over-year
- ➤Annualized revenue run rate exceeds $1 billion following acquisitions
- ➤Q4 2026 revenue guidance is $250 million to $265 million
- ➤Q1 2027 revenue guidance is $280 million to $300 million
Expert Statements
John Mazarakis, Chief Executive Officer of Vireo Growth
“The third quarter marked another important period of progress for Vireo as we continued executing our strategy of disciplined, capital-efficient consolidation. With an annualized revenue run rate exceeding $1 billion, we have established significant scale, but our focus remains on leveraging that scale to drive stronger operating and financial performance.”
John Mazarakis, Chief Executive Officer of Vireo Growth
“We are beginning to see encouraging results, exemplified by 4% pro forma year-over-year retail revenue growth in the third quarter, a proxy for same store sales growth, as our experienced local teams integrate acquisitions, strengthen brands, and identify opportunities to improve performance across our markets. Looking ahead to 2027, we believe our decentralized operating model, growing leadership bench and disciplined approach to capital allocation position us to continue building a platform that is more valuable than the sum of its parts.”
Q3 GAAP revenue of $253.7 million increased 177% year-over-year, driven by recently closed M&A transactions.
Q3 proforma revenue of $277.0 million, gives effect to the acquisitions of C21 Investments, certain PharmaCann Colorado assets, and the Cannabist Colorado assets under MSA as if they were completed on July 1, 2026.
Get started
Create a free account to read the full story.